Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$53.69 - $65.47 $204,881 - $249,833
-3,816 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$44.53 - $58.9 $1.11 Million - $1.47 Million
-25,000 Reduced 86.76%
3,816 $217,000
Q4 2018

Feb 13, 2019

BUY
$47.64 - $71.26 $440,003 - $658,157
9,236 Added 47.17%
28,816 $1.43 Million
Q2 2018

Aug 13, 2018

BUY
$48.15 - $56.68 $942,777 - $1.11 Million
19,580 New
19,580 $1.02 Million
Q1 2018

May 14, 2018

SELL
$46.03 - $61.28 $5.41 Million - $7.2 Million
-117,437 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$50.58 - $60.79 $2.23 Million - $2.68 Million
-44,139 Reduced 27.32%
117,437 $6.87 Million
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $8.65 Million - $11 Million
161,576
161,576 $8.96 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.